Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer-Associated Fibroblasts as Players in Cancer Development and Progression and Their Role in Targeted Radionuclide Imaging and Therapy
Sofia Koustoulidou, Mark W. H. Hoorens, Simone U. Dalm, et al.
Cancers (2021) Vol. 13, Iss. 5, pp. 1100-1100
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Fibroblast Activation Protein-α as a Target in the Bench-to-Bedside Diagnosis and Treatment of Tumors: A Narrative Review
Lei Xin, Jinfang Gao, Ziliang Zheng, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 115
FAP and FAPI-PET/CT in Malignant and Non-Malignant Diseases: A Perfect Symbiosis?
Katharina Dendl, Stefan A. Koerber, Clemens Kratochwil, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 4946-4946
Open Access | Times Cited: 108
Evans blue-modified radiolabeled fibroblast activation protein inhibitor as long-acting cancer therapeutics
Xuejun Wen, Peng‐Fei Xu, Mengqi Shi, et al.
Theranostics (2021) Vol. 12, Iss. 1, pp. 422-433
Open Access | Times Cited: 87
First-In-Human Results on the Biodistribution, Pharmacokinetics, and Dosimetry of [177Lu]Lu-DOTA.SA.FAPi and [177Lu]Lu-DOTAGA.(SA.FAPi)2
Sanjana Ballal, Madhav Prasad Yadav, Euy Sung Moon, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 12, pp. 1212-1212
Open Access | Times Cited: 84
Roles of the CXCL8-CXCR1/2 Axis in the Tumor Microenvironment and Immunotherapy
Zhi‐Jian Han, Yang-Bing Li, Luxi Yang, et al.
Molecules (2021) Vol. 27, Iss. 1, pp. 137-137
Open Access | Times Cited: 81
FAPI-PET/CT in Cancer Imaging: A Potential Novel Molecule of the Century
Rong Huang, Yu Pu, Shun Huang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 67
Fibroblast Activation Protein Activates Macrophages and Promotes Parenchymal Liver Inflammation and Fibrosis
Aiting Yang, Yong-Ook Kim, Xuzhen Yan, et al.
Cellular and Molecular Gastroenterology and Hepatology (2022) Vol. 15, Iss. 4, pp. 841-867
Open Access | Times Cited: 63
Fatty acid-conjugated radiopharmaceuticals for fibroblast activation protein-targeted radiotherapy
Pu Zhang, Mengxin Xu, Jie Ding, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2021) Vol. 49, Iss. 6, pp. 1985-1996
Closed Access | Times Cited: 56
Nectin-4-targeted immunoSPECT/CT imaging and photothermal therapy of triple-negative breast cancer
Fuqiang Shao, Zhidi Pan, Yu Long, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 40
Targeting fibroblast activation protein (FAP): advances in CAR-T cell, antibody, and vaccine in cancer immunotherapy
Sedigheh Shahvali, Niloufar Rahiman, Mahmoud Reza Jaafari, et al.
Drug Delivery and Translational Research (2023) Vol. 13, Iss. 7, pp. 2041-2056
Closed Access | Times Cited: 36
99mTc-Labeled Quinolone-Based Novel Skeletal Tracers for Tumor Visualization through Fibroblast Activation Protein
Yang Luo, Pengjun Zhang, Zihan Wu, et al.
Journal of Medicinal Chemistry (2025)
Closed Access | Times Cited: 1
New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress
Surachet Imlimthan, Euy Sung Moon, Hendrik Rathke, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 10, pp. 1023-1023
Open Access | Times Cited: 47
Rational Design and Pharmacomodulation of Protein-Binding Theranostic Radioligands for Targeting the Fibroblast Activation Protein
Lingxin Meng, Jianyang Fang, Liang Zhao, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 12, pp. 8245-8257
Closed Access | Times Cited: 35
Clinical applications of fibroblast activation protein inhibitor positron emission tomography (FAPI-PET)
Yuriko Mori, Emil Novruzov, Dominik Schmitt, et al.
npj Imaging (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 7
Unraveling the intricacies of cancer‐associated fibroblasts: a comprehensive review on metabolic reprogramming and tumor microenvironment crosstalk
Sana Ahuja, Niti Sureka, Sufian Zaheer
Apmis (2024)
Closed Access | Times Cited: 6
The Contribution of 68Ga-FAPI-04 PET/CT to Staging and Prognosis in Gastric Cancer
Ediz Beyhan, Tevfik Fikret Çermik, Özge Erol Fenercioğlu, et al.
Clinical Nuclear Medicine (2024) Vol. 49, Iss. 10, pp. e485-e491
Closed Access | Times Cited: 6
Radionuclide imaging and therapy directed towards the tumor microenvironment: a multi-cancer approach for personalized medicine
Circe D. van der Heide, Simone U. Dalm
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 49, Iss. 13, pp. 4616-4641
Open Access | Times Cited: 27
Expression of fibroblast activation protein in lung cancer and its correlation with tumor glucose metabolism and histopathology
Xiaohong Chen, Xinran Liu, Lijuan Wang, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 49, Iss. 8, pp. 2938-2948
Closed Access | Times Cited: 26
Could Fibroblast Activation Protein (FAP)-Specific Radioligands Be Considered as Pan-Tumor Agents?
Hessamoddin Roustaei, Zahra Kiamanesh, Emran Askari, et al.
Contrast Media & Molecular Imaging (2022) Vol. 2022, Iss. 1
Open Access | Times Cited: 25
Fibroblast Activation Protein Inhibitor–Based Radionuclide Therapies: Current Status and Future Directions
Manish Ora, Neetu Soni, Aftab Hasan Nazar, et al.
Journal of Nuclear Medicine (2023) Vol. 64, Iss. 7, pp. 1001-1008
Open Access | Times Cited: 15
High Affinity and FAP-Targeted Radiotracers: A Potential Design Strategy to Improve the Pharmacokinetics and Tumor Uptake for FAP Inhibitors
Yinwen Wang, Hongmei Yuan, Nan Liu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 13, pp. 8614-8627
Closed Access | Times Cited: 14
Beyond Small Molecules: Antibodies and Peptides for Fibroblast Activation Protein Targeting Radiopharmaceuticals
Xiaona Sun, Yuxuan Wu, Xingkai Wang, et al.
Pharmaceutics (2024) Vol. 16, Iss. 3, pp. 345-345
Open Access | Times Cited: 5
[18F] AlF-NOTA-FAPI-04 PET/CT can predict treatment response and survival in patients receiving chemotherapy for inoperable pancreatic ductal adenocarcinoma
Ziyuan Zhu, Kai Cheng, Yun Zhang, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 50, Iss. 11, pp. 3425-3438
Closed Access | Times Cited: 12
Metabolic vulnerabilities in cancer: A new therapeutic strategy
Mohamed El‐Tanani, Syed Arman Rabbani, Yahia El‐Tanani, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 201, pp. 104438-104438
Closed Access | Times Cited: 4
In vitro and in vivo analyses of eFAP: a novel FAP-targeting small molecule for radionuclide theranostics and other oncological interventions
Circe D. van der Heide, Hanyue Ma, Mark W. H. Hoorens, et al.
EJNMMI Radiopharmacy and Chemistry (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top